Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Protalix BioTherapeutics, Inc. (DE) Common Stock (NY:PLX)

1.760 -0.050 (-2.76%)
Official Closing Price Updated: 4:10 PM EST, Dec 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 588,529
Open 1.840
Bid (Size) 1.730 (100)
Ask (Size) 1.840 (53,000)
Prev. Close 1.810
Today's Range 1.740 - 1.850
52wk Range 1.320 - 3.100
Shares Outstanding 73,633,583
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Top stock movements in today's session. ↗
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Why Is Protalix BioTherapeutics Stock Falling On Friday? ↗
EMA issues a negative opinion on Protalix and Chiesi's Elfabrio revised dosing for Fabry disease, citing insufficient data to confirm efficacy. 
Via Benzinga

Performance

YTD
-10.7%
-10.7%
1 Month
-6.9%
-6.9%
3 Month
-9.7%
-9.7%
6 Month
+28.5%
+28.5%
1 Year
+0.6%
+0.6%

More News

Read More
News headline image
Which stocks are gapping on Friday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
Protalix BioTherapeutics Stock Tumbled 28% Today: Why The Latest CHMP Opinion Is Sparking Concerns Among Investors? ↗
Via Stocktwits
News headline image
Earnings Scheduled For August 14, 2025 ↗
Via Benzinga
News headline image
Preview: Protalix BioTherapeutics's Earnings ↗
Via Benzinga
News headline image
Earnings Scheduled For November 13, 2025 ↗
Via Benzinga
News headline image
Preview: Protalix BioTherapeutics's Earnings ↗
Via Benzinga
News headline image
PLX Investors Have Opportunity to Join Protalix BioTherapeutics, Inc. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
PLX Investors Have Opportunity to Join Protalix BioTherapeutics, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
Via ACCESS Newswire
News headline image
Protalix BioTherapeutics to Present at Investor Summit Virtual
Via ACCESS Newswire
News headline image
Protalix Revenue Jumps 16 Percent in Q2 ↗
Via The Motley Fool
News headline image
Top movers in Friday's session ↗
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Friday's session. ↗
Via Chartmill
News headline image
The market is filled with gapping stocks in Friday's session. ↗
Via Chartmill
News headline image
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Earnings Scheduled For May 9, 2025 ↗
Via Benzinga
News headline image
Uncovering Potential: Protalix BioTherapeutics's Earnings Preview ↗
Via Benzinga
News headline image
Regulus Downgraded By Analysts After $1.7B Novartis Buyout Offer — Street Sees Limited Upside Ahead ↗
Via Stocktwits
Topics Stocks
News headline image
Evaluating PROTALIX BIOTHERAPEUTICS INC (NYSEARCA:PLX) using Mark Minervini’s winning stock formula ↗
Via Chartmill
News headline image
Does PROTALIX BIOTHERAPEUTICS INC (NYSEARCA:PLX) show the characteristics of a Minervini super stock? ↗
Via Chartmill

Frequently Asked Questions

Is Protalix BioTherapeutics, Inc. (DE) Common Stock publicly traded?
Yes, Protalix BioTherapeutics, Inc. (DE) Common Stock is publicly traded.
What exchange does Protalix BioTherapeutics, Inc. (DE) Common Stock trade on?
Protalix BioTherapeutics, Inc. (DE) Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Protalix BioTherapeutics, Inc. (DE) Common Stock?
The ticker symbol for Protalix BioTherapeutics, Inc. (DE) Common Stock is PLX on the New York Stock Exchange
What is the current price of Protalix BioTherapeutics, Inc. (DE) Common Stock?
The current price of Protalix BioTherapeutics, Inc. (DE) Common Stock is 1.760
When was Protalix BioTherapeutics, Inc. (DE) Common Stock last traded?
The last trade of Protalix BioTherapeutics, Inc. (DE) Common Stock was at 12/17/25 04:10 PM ET
What is the market capitalization of Protalix BioTherapeutics, Inc. (DE) Common Stock?
The market capitalization of Protalix BioTherapeutics, Inc. (DE) Common Stock is 129.60M
How many shares of Protalix BioTherapeutics, Inc. (DE) Common Stock are outstanding?
Protalix BioTherapeutics, Inc. (DE) Common Stock has 130M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.